These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 16964400

  • 21. CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer.
    Wang G, Cheng Z, Liu F, Zhang H, Li J, Li F.
    Cell Signal; 2015 Jul; 27(7):1369-79. PubMed ID: 25843777
    [Abstract] [Full Text] [Related]

  • 22. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
    Ambrosio MR, Di Serio C, Danza G, Rocca BJ, Ginori A, Prudovsky I, Marchionni N, Del Vecchio MT, Tarantini F.
    Diagn Pathol; 2016 May 25; 11(1):45. PubMed ID: 27225200
    [Abstract] [Full Text] [Related]

  • 23. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
    Dungwa JV, Hunt LP, Ramani P.
    BMC Cancer; 2011 Sep 12; 11():390. PubMed ID: 21910893
    [Abstract] [Full Text] [Related]

  • 24. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?
    Kaluz S, Kaluzová M, Liao SY, Lerman M, Stanbridge EJ.
    Biochim Biophys Acta; 2009 Apr 12; 1795(2):162-72. PubMed ID: 19344680
    [Abstract] [Full Text] [Related]

  • 25. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL.
    Cancer Res; 2001 Nov 01; 61(21):7992-8. PubMed ID: 11691824
    [Abstract] [Full Text] [Related]

  • 26. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients.
    Kaya AO, Gunel N, Benekli M, Akyurek N, Buyukberber S, Tatli H, Coskun U, Yildiz R, Yaman E, Ozturk B.
    J BUON; 2012 Nov 01; 17(4):663-8. PubMed ID: 23335522
    [Abstract] [Full Text] [Related]

  • 27. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
    Pastorek J, Pastorekova S.
    Semin Cancer Biol; 2015 Apr 01; 31():52-64. PubMed ID: 25117006
    [Abstract] [Full Text] [Related]

  • 28. Activation of hypoxia-induced transcription in normoxia.
    Hägg M, Wennström S.
    Exp Cell Res; 2005 May 15; 306(1):180-91. PubMed ID: 15878343
    [Abstract] [Full Text] [Related]

  • 29. Hypoxic tumor microenvironment in advanced retinoblastoma.
    Sudhakar J, Venkatesan N, Lakshmanan S, Khetan V, Krishnakumar S, Biswas J.
    Pediatr Blood Cancer; 2013 Oct 15; 60(10):1598-601. PubMed ID: 23804414
    [Abstract] [Full Text] [Related]

  • 30. Expression pattern of carbonic anhydrase IX in Medullary thyroid carcinoma supports a role for RET-mediated activation of the HIF pathway.
    Takacova M, Bullova P, Simko V, Skvarkova L, Poturnajova M, Feketeova L, Babal P, Kivela AJ, Kuopio T, Kopacek J, Pastorek J, Parkkila S, Pastorekova S.
    Am J Pathol; 2014 Apr 15; 184(4):953-965. PubMed ID: 24518567
    [Abstract] [Full Text] [Related]

  • 31. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype.
    Barathova M, Takacova M, Holotnakova T, Gibadulinova A, Ohradanova A, Zatovicova M, Hulikova A, Kopacek J, Parkkila S, Supuran CT, Pastorekova S, Pastorek J.
    Br J Cancer; 2008 Jan 15; 98(1):129-36. PubMed ID: 18026188
    [Abstract] [Full Text] [Related]

  • 32. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors.
    Dubois L, Douma K, Supuran CT, Chiu RK, van Zandvoort MA, Pastoreková S, Scozzafava A, Wouters BG, Lambin P.
    Radiother Oncol; 2007 Jun 15; 83(3):367-73. PubMed ID: 17502120
    [Abstract] [Full Text] [Related]

  • 33. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L, Biesová Z, Pastoreková S, Kettmann R, Pastorek J.
    Int J Oncol; 2005 Apr 15; 26(4):1121-7. PubMed ID: 15754010
    [Abstract] [Full Text] [Related]

  • 34. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M, Reddemann R, Said HM, Holzhausen HJ, Taubert H, Becker A, Kuhnt T, Hänsgen G, Dunst J, Vordermark D.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1481-7. PubMed ID: 17056190
    [Abstract] [Full Text] [Related]

  • 35. Deficient carbonic anhydrase 9 expression in UPR-impaired cells is associated with reduced survival in an acidic microenvironment.
    van den Beucken T, Ramaekers CH, Rouschop K, Koritzinsky M, Wouters BG.
    Radiother Oncol; 2009 Sep 01; 92(3):437-42. PubMed ID: 19615771
    [Abstract] [Full Text] [Related]

  • 36. Role of the HBx oncoprotein in carbonic anhydrase 9 induction.
    Holotnakova T, Tylkova L, Takacova M, Kopacek J, Petrik J, Pastorekova S, Pastorek J.
    J Med Virol; 2010 Jan 01; 82(1):32-40. PubMed ID: 19950233
    [Abstract] [Full Text] [Related]

  • 37. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
    Cecchi A, Hulikova A, Pastorek J, Pastoreková S, Scozzafava A, Winum JY, Montero JL, Supuran CT.
    J Med Chem; 2005 Jul 28; 48(15):4834-41. PubMed ID: 16033263
    [Abstract] [Full Text] [Related]

  • 38. Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.
    Grabmaier K, A de Weijert MC, Verhaegh GW, Schalken JA, Oosterwijk E.
    Oncogene; 2004 Jul 22; 23(33):5624-31. PubMed ID: 15184875
    [Abstract] [Full Text] [Related]

  • 39. Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.
    Perut F, Carta F, Bonuccelli G, Grisendi G, Di Pompo G, Avnet S, Sbrana FV, Hosogi S, Dominici M, Kusuzaki K, Supuran CT, Baldini N.
    Expert Opin Ther Targets; 2015 Jul 22; 19(12):1593-605. PubMed ID: 26357839
    [Abstract] [Full Text] [Related]

  • 40. Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.
    Najy AJ, Dyson G, Jena BP, Lin CY, Kim HR.
    Am J Physiol Cell Physiol; 2016 Feb 15; 310(4):C293-304. PubMed ID: 26157007
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.